These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 23738435

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of Wilson's disease.
    Subramanian I, Vanek ZF, Bronstein JM.
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
    [Abstract] [Full Text] [Related]

  • 4. Current Drug Managements of Wilson's Disease: From West to East.
    Li WJ, Chen C, You ZF, Yang RM, Wang XP.
    Curr Neuropharmacol; 2016 Jul; 14(4):322-5. PubMed ID: 26639459
    [Abstract] [Full Text] [Related]

  • 5. Clinical considerations for an effective medical therapy in Wilson's disease.
    Weiss KH, Stremmel W.
    Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML.
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improvement of cardiovascular autonomic dysfunction following anti-copper therapy in Wilson's disease.
    Deguchi K, Sasaki I, Touge T, Tsukaguchi M, Ikeda K, Shimamura M, Urai Y, Watanabe S, Takeuchi H, Kuriyama S.
    J Neurol; 2005 Apr; 252(4):495-7. PubMed ID: 15726258
    [No Abstract] [Full Text] [Related]

  • 13. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC, Hassan Y, Aziz NA, Ghazali R, Awaisu A.
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [Abstract] [Full Text] [Related]

  • 14. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F.
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [Abstract] [Full Text] [Related]

  • 15. Wilson's disease: current status.
    Yarze JC, Martin P, Muñoz SJ, Friedman LS.
    Am J Med; 1992 Jun; 92(6):643-54. PubMed ID: 1605146
    [Abstract] [Full Text] [Related]

  • 16. Wilson's disease: clinical, genetic and pharmacological findings.
    Leggio L, Addolorato G, Abenavoli L, Gasbarrini G.
    Int J Immunopathol Pharmacol; 2005 Jun; 18(1):7-14. PubMed ID: 15698506
    [Abstract] [Full Text] [Related]

  • 17. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J, Yoshino M, Watari H, Yoshida I, Motohiro T, Yamashita F, Okano Y, Hashimoto T.
    Dev Pharmacol Ther; 1992 Jun; 19(1):6-9. PubMed ID: 1307347
    [Abstract] [Full Text] [Related]

  • 18. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F, Cardin R, D'inca R, Naccarato R, Sturniolo GC.
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [Abstract] [Full Text] [Related]

  • 19. Novel therapeutic approaches to the treatment of Wilson's disease.
    Brewer GJ.
    Expert Opin Pharmacother; 2006 Feb; 7(3):317-24. PubMed ID: 16448326
    [Abstract] [Full Text] [Related]

  • 20. Wilson's disease.
    Ferenci P.
    Clin Liver Dis; 1998 Feb; 2(1):31-49, v-vi. PubMed ID: 15560044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.